{"doi":"10.30809/phe.3.2016.2","title":"Budget impact analysis of ipilimumab usage in patients with metastatic melanoma","abstract":null,"journal":"Pharmacoeconomics: theory and practice","year":2016,"id":600770,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1540258,"name":"A.R. Skripnik","orcid":null,"position":1,"is_corresponding":false},{"id":1540257,"name":"A.Yu. Kulikov","orcid":"0000-0002-7025-1185","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Budget impact analysis of ipilimumab usage in patients with metastatic melanoma","abstract":"Melanoma is a malignant tumor that develops from transformed melanocytes, located mainly in the skin. According to Russian statistics, the incidence of melanoma in 2014 was 9,390 new cases In 2004In -2014, melanoma , melanoma prevalence rate per 100,000 population increased on average by 4.2% per year. High prevalence of melanoma and frequent poor prognosis necessitate search of innovative treatment methods and use of high-tech drugs.","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21097893","pmcid":null,"openalex_id":"https://openalex.org/W2805464105","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.21509158,"influential_citations":0,"citation_trend":[],"oa_status":"bronze","license":null,"oa_locations":[{"url":"https://pharmacoeconom.com/netcat_files/401/620/Budget_impact_analysis_of_ipilimumab_usage_in_patients_with_metastatic_melanoma.pdf","host_type":"journal"},{"url":"https://pharmacoeconom.com/netcat_files/401/620/Budget_impact_analysis_of_ipilimumab_usage_in_patients_with_metastatic_melanoma.pdf","host_type":"publisher"},{"url":"https://doi.org/10.30809/phe.3.2016.2","host_type":"journal"}],"fields_of_study":["Biosimilars and Bioanalytical Methods","Pharmaceutical Economics and Policy","Health Systems, Economic Evaluations, Quality of Life"],"mesh_terms":[],"keywords":["Ipilimumab","Metastatic melanoma","Medicine","Melanoma","Oncology","Internal medicine","Cancer research","Immunotherapy","Cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T14:06:22.990087Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}